Table 2 Univariate survival analyses with 5-year overall survival rates
From: Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
5-yr OSR | p value | ||
|---|---|---|---|
Location | 0.006 | ||
Non-uterine | 82.6% | ||
Uterine | 41.2% | ||
Gender | 0.07 | ||
Male | 86.2% | ||
Female | 53.4% | ||
Size | 0.71 | ||
≤5 cm | 66.7% | ||
5-10 cm | 57.9% | ||
>10 cm | 32.4% | ||
Initial metastatic | <0.001 | ||
No | 91.3% | ||
Yes | 29.6% | ||
Grading | 0.06 | ||
G1 + 2 | 73.6% | ||
G3 | 50.5% | ||
Age | 0.06 | ||
>56.6a | 75.6% | ||
≤56.6a | 49.2% | ||
Gender (NULMS) | 0.96 | ||
Female | 77.9% | ||
Male | 76.7% |